Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
3
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

55.6%

5 of 9 finished

Non-Completion Rate

44.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(4)

Detailed Status

Completed5
Withdrawn3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

withdrawn333%
completed556%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9